MAPKAPK5-AS1/miR-515-5p/CAB39 Axis Contributes to Non-small Cell Lung Cancer Cell Proliferation and Migration. 2023

Yueming Zhao, and Danyang Zhou, and Yuan Yuan, and Yubao Chen, and Kai Zhang, and Yan Tan, and Surong Fang
Department of Respiratory, Nanjing First Hospital, Qinhuai District, No.68, Changle Road, Nanjing, 210012, Jiangsu, China.

Several studies have elucidated the pivotal function that long noncoding RNAs (lncRNAs) exerted on the initiation and development of various human carcinomas, encompassing non-small cell lung cancer (NSCLC). In spite of the fact that lncRNA MAPKAPK5 antisense RNA 1 (MAPKAPK5-AS1) has already been investigated by researchers and confirmed to play oncogenic roles in colorectal cancer, the underlying regulatory function of MAPKAPK5-AS1 in NSCLC cells still remain unclear. In our research, we found that MAPKAPK5-AS1 was expressed at high levels in NSCLC cells. Biological functional assays unclosed that downregulation of MAPKAPK5-AS1 repressed proliferative and migratory capacities whereas promoted apoptotic level in NSCLC cells. Molecular mechanism experiments confirmed that, in NSCLC cells, MAPKAPK5-AS1 combined with miR-515-5p and negatively modulated miR-515-5p expression level. Besides, calcium-binding protein 39 (CAB39) expression level was verified to be negatively modulated by miR-515-5p whereas positively modulated by MAPKAPK5-AS1 in NSCLC cells. Furthermore, rescued-function assays disclosed that inhibited miR-515-5p expression or overexpressed CAB39 could restore the suppressive influence of MAPKAPK5-AS1 silence on NSCLC progression. In summary, MAPKAPK5-AS1 upregulates CAB39 expression level to facilitate NSCLC progression by sequestering miR-515-5p, providing promising biomarkers for NSCLC treatment.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Yueming Zhao, and Danyang Zhou, and Yuan Yuan, and Yubao Chen, and Kai Zhang, and Yan Tan, and Surong Fang
January 2021, Technology in cancer research & treatment,
Yueming Zhao, and Danyang Zhou, and Yuan Yuan, and Yubao Chen, and Kai Zhang, and Yan Tan, and Surong Fang
May 2021, Cell cycle (Georgetown, Tex.),
Yueming Zhao, and Danyang Zhou, and Yuan Yuan, and Yubao Chen, and Kai Zhang, and Yan Tan, and Surong Fang
December 2021, Bioengineered,
Yueming Zhao, and Danyang Zhou, and Yuan Yuan, and Yubao Chen, and Kai Zhang, and Yan Tan, and Surong Fang
December 2020, European journal of histochemistry : EJH,
Yueming Zhao, and Danyang Zhou, and Yuan Yuan, and Yubao Chen, and Kai Zhang, and Yan Tan, and Surong Fang
January 2020, Cancer management and research,
Yueming Zhao, and Danyang Zhou, and Yuan Yuan, and Yubao Chen, and Kai Zhang, and Yan Tan, and Surong Fang
December 2023, Histology and histopathology,
Yueming Zhao, and Danyang Zhou, and Yuan Yuan, and Yubao Chen, and Kai Zhang, and Yan Tan, and Surong Fang
January 2020, OncoTargets and therapy,
Yueming Zhao, and Danyang Zhou, and Yuan Yuan, and Yubao Chen, and Kai Zhang, and Yan Tan, and Surong Fang
January 2020, OncoTargets and therapy,
Yueming Zhao, and Danyang Zhou, and Yuan Yuan, and Yubao Chen, and Kai Zhang, and Yan Tan, and Surong Fang
January 2022, BMC pulmonary medicine,
Yueming Zhao, and Danyang Zhou, and Yuan Yuan, and Yubao Chen, and Kai Zhang, and Yan Tan, and Surong Fang
August 2020, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!